Bladder Cancer
Updated Guidelines for Treatment of Non-Metastatic MBIC to be Presented at AUA Meeting
The AUA has teamed up with ASCO, ASTRO, and SUO to provide new guidelines for non-metastatic MBIC treatment.
Latest in Urology
Bladder Cancer
Updated Guidelines for Treatment of Non-Metastatic MBIC to be Presented at AUA Meeting
The AUA has teamed up with ASCO, ASTRO, and SUO to provide new guidelines for non-metastatic MBIC treatment.
Mar 10, 2017
| Bladder Cancer Content Hub, Hematology-Oncology, Internal Medicine, Men's Health, Urology, Women’s Health
Multiple clinical trials are currently underway examining the possible synergistic effects of combining chemotherapy with immunotherapies for patients with bladder cancer and other...
Bacillus Calmette-Guérin (BCG) is an effective biologic therapy widely used in patients with non-muscle invasive bladder cancer. Sanofi recently announced their intent to discontinue BCG production, leaving Merck as the sole BCG supplier to U.S. patients. Urologists are concerned that a potential BCG...
Prostate Exam Practice Progresses
Jul 8, 2016
